trending Market Intelligence /marketintelligence/en/news-insights/trending/eoxwhekvkzl-7dsuklaiqg2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In this list

Pluristem to advance blood transplant study

Mining Exploration Insights – January, 2020

Case Study: Leveraging a Comprehensive Project Finance Credit Assessment Scorecard

Despite Fewer CUSIP Requests in December, Overall Total Increased Year Over Year

Traditional Multichannel Video Plummets In Rural Areas

Pluristem to advance blood transplant study

Pluristem Therapeutics Inc. is collaborating with the New York Blood Center to advance studies on its PLX-R18 therapy for umbilical cord blood transplantation.

The study will be funded by a conditional award of $900,000 from the Israel-U.S. Binational Industrial Research and Development Foundation with Pluristem providing the PLX-R18 cells and the NYBC conducting and supporting the studies.